Most recently, the biotech executive helmed one of the fastest-growing public companies in Baltimore last year.
{iframe}https://www.bizjournals.com/washington/news/2019/04/22/former-medimmune-president-tapped-to-lead-canadian.html{/iframe}
Ex-MedImmune exec Peter Greenleaf to lead Canadian biotech Aurinia Pharmaceuticals – Washington Business Journal
Most recently, the biotech executive helmed one of the fastest-growing public companies in Baltimore last year.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.